Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2006

01-09-2006 | Epidemiology

Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer

Authors: Bette J. Caan, Jennifer A. Emond, Loki Natarajan, Adrienne Castillo, Erica P. Gunderson, Laurel Habel, Lovell Jones, Vicky A. Newman, Cheryl L. Rock, Martha L. Slattery, Marcia L. Stefanick, Barbara Sternfeld, Cynthia A. Thomson, John P. Pierce

Published in: Breast Cancer Research and Treatment | Issue 1/2006

Login to get access
Metadata
Title
Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer
Authors
Bette J. Caan
Jennifer A. Emond
Loki Natarajan
Adrienne Castillo
Erica P. Gunderson
Laurel Habel
Lovell Jones
Vicky A. Newman
Cheryl L. Rock
Martha L. Slattery
Marcia L. Stefanick
Barbara Sternfeld
Cynthia A. Thomson
John P. Pierce
Publication date
01-09-2006
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2006
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9179-y

Other articles of this Issue 1/2006

Breast Cancer Research and Treatment 1/2006 Go to the issue

OriginalPaper

Factors affecting patients’ perceptions of choice regarding adjuvant chemotherapy for breast cancer

Epidemiology

IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH–DNA adducts to breast cancer risk

Preclinical study

Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines

Epidemiology

Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene

Epidemiology

BRCA1-positive breast cancers in young women from Poland

Letter to the Editor

Optical coherence tomography in tamoxifen retinopathy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits